Trellus Management Company’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

Trellus Management Company’s Portfolio AMPE Stock Details AMPE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-48	Closed	-$49K	–	78
2018 Q1	$49K	Buy	+48	New	+$40.2K	0.09%	63
2016 Q2	–	Sell	-278	Closed	-$304K	–	79
2016 Q1	$187K	Sell	278 -3	-1%	-$2.02K	0.33%	56
2015 Q4	$295K	Sell	281 -108	-28%	-$107K	0.43%	62
2015 Q3	$337K	Hold	389	–	–	0.49%	57
2015 Q2	$277K	Sell	389 -29	-7%	-$30.9K	0.31%	73
2015 Q1	$945K	Sell	418 -124	-23%	-$211K	1.13%	24
2014 Q4	$557K	Sell	542 -25	-4%	-$26.7K	0.82%	39
2014 Q3	$600K	Buy	567 +150	+36%	+$253K	0.51%	53
2014 Q2	$1.04M	Buy	417 +33	+9%	+$67.3K	0.88%	27
2014 Q1	$732K	Buy	+384	New	+$908K	0.65%	40

Other funds holding AMPE

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

KCM

Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

CCMW

Cypress Capital Management (Wyoming) Sheridan, Wyoming $108M AUM 54.47% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Transform Wealth Greenwood Village, Colorado $1.65B AUM 19.1% 1-Year Est. Return

Trellus Management Company's AMPE Position: Q2 2018 in Review

Trellus Management Company sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2018, closing a stake of 48 shares — an estimated $49K sold.

Trellus Management Company first reported a position in AMPE in Q1 2014 and held it in 10 quarters. The position peaked at $1.04M in Q2 2014. 86 funds tracked by Wall St. Rank hold AMPE as of Q2 2018.

Trellus Management Company reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2018 after selling out during the quarter.
Trellus Management Company sold 48 Ampio Pharmaceuticals Inc. shares in Q2 2018, an estimated $49K.
Trellus Management Company first reported a position in Ampio Pharmaceuticals Inc. in Q1 2014 and held it in 10 quarters.
Trellus Management Company's Ampio Pharmaceuticals Inc. position peaked at $1.04M in Q2 2014.
86 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2018.

Based on Trellus Management Company's 13F filing for Q2 2018, filed 25 Jul 2018.